Advertisement ClinicalRM receives medical research contract by NMRC - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ClinicalRM receives medical research contract by NMRC

US-based Clinical Research Management (ClinicalRM), a Contract Research Organization has received two contracts by the Navy Medical Research Center (NMRC) under its Omnibus III program.

The program requires ClinicalRM to provide an infrastructure of personnel, materials, equipment, facilities, science, and technology that will sustain an acceptable level of medical research.

The Omnibus III contract intends to conduct R&D across its enterprise and is an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract, the company says.

ClinicalRM founder and CEO Said Tifft said the company will extend their support to the Navy as its priority is to improve the health and safety of the warfighters and their families through medical research.

Actiivity under the Omnibus III contract is expected to begin in the new fiscal year.